Furosemide Tablets
SOL #: SPE2D221R0110Award Notice
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Charlotte, NC
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Jul 2, 2021
2
Last Updated
Nov 25, 2025
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
People
Points of Contact
Phyllis DaraioPRIMARY
Jason WraySECONDARY
Files
Versions
Version 8
Award Notice
Posted: Nov 25, 2025
Version 7
Award Notice
Posted: Nov 22, 2024
Version 6Viewing
Award Notice
Posted: Nov 24, 2023
Version 5
Award Notice
Posted: Aug 7, 2023
Version 4
Award Notice
Posted: Nov 10, 2022
Version 3
Award Notice
Posted: Dec 8, 2021
Version 2
Solicitation
Posted: Jul 30, 2021
Version 1
Pre-Solicitation
Posted: Jul 2, 2021